Asthma management device nears US and EU
This article was originally published in Clinica
A New Zealand company is moving towards US and European regulatory approval of an inhaler with a built-in miniature computer that could significantly improve the treatment of asthma and other diseases treated with inhaled drugs.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.